Kaltenbach Tonya, Friedland Shai, Maheshwari Anamika, Ouyang Daniel, Rouse Robert V, Wren Sherry, Soetikno Roy
Division of Gastroenterology, Department of Medicine, Veterans Affairs Palo Alto Health Care System, Stanford University School of Medicine, Palo Alto, California, USA.
Gastrointest Endosc. 2007 May;65(6):857-65. doi: 10.1016/j.gie.2006.11.035.
Nonpolypoid (flat and depressed) colorectal lesions are increasingly recognized. Their endoscopic removal requires specialized EMR techniques, which are more complex to perform. Outcomes data on EMR of nonpolypoid neoplasms in the United States is needed.
To determine the safety and efficacy of EMR in the resection of nonpolypoid colorectal neoplasms > or = 1 cm.
Retrospective analysis.
Veterans Affairs Palo Alto Health Care System.
Over a 5-year period, patients who underwent EMR for nonpolypoid colorectal lesions > or = 1 cm.
A standardized approach that included lesion assessment, classification, inject-and-cut EMR technique, reassessment, and treatment of residual tissue.
Complete resection, bleeding, perforation, development of advanced cancer, and death.
A total of 100 patients (125 lesions: 117 flat and 8 depressed) met inclusion criteria. Mean size was 16.7 +/- 7 mm (range, 10-50 mm). Histology included 5 submucosal invasive cancers, 5 carcinomas in situ, and 91 adenomas. Thirty-eight patients (48 lesions) did not receive surveillance colonoscopy: 8 had surgery, 16 had hyperplastic pathology, and 14 did not undergo repeat examination. Surveillance colonoscopy was performed on 62 patients (77 lesions). Complete resection was achieved in 100% of these patients after 1 to 3 surveillance colonoscopies. All patients received follow-up (mean [standard deviation] = 4.5 +/- 1.4 years); none developed colorectal cancer or metastasis.
Single endoscopist, retrospective study.
A standardized EMR (inject-and-cut) technique is a safe and curative treatment option in nonpolypoid colorectal neoplasms (> or = 1 cm) in the United States.
非息肉样(扁平及凹陷性)结直肠病变越来越受到关注。其内镜下切除需要专门的内镜黏膜切除术(EMR)技术,操作更为复杂。美国需要非息肉样肿瘤EMR的疗效数据。
确定EMR切除直径大于或等于1 cm的非息肉样结直肠肿瘤的安全性和有效性。
回顾性分析。
退伍军人事务部帕洛阿尔托医疗保健系统。
在5年期间,接受EMR治疗直径大于或等于1 cm的非息肉样结直肠病变的患者。
采用标准化方法,包括病变评估、分类、注射-切除EMR技术、重新评估以及残余组织的处理。
完全切除、出血、穿孔、进展期癌症的发生及死亡。
共有100例患者(125处病变:117处扁平病变和8处凹陷病变)符合纳入标准。平均大小为16.7±7 mm(范围10 - 50 mm)。组织学检查包括5例黏膜下浸润癌、5例原位癌和91例腺瘤。38例患者(48处病变)未接受结肠镜监测:8例接受了手术,16例病理为增生性病变,14例未接受复查。62例患者(77处病变)接受了结肠镜监测。在1至3次结肠镜监测后,这些患者均实现了完全切除。所有患者均接受了随访(平均[标准差]=4.5±1.4年);均未发生结直肠癌或转移。
单内镜医师、回顾性研究。
在美国,标准化的EMR(注射-切除)技术是治疗直径大于或等于1 cm的非息肉样结直肠肿瘤的一种安全且可治愈的治疗选择。